Cardio Diagnostics Holdings, Inc. has submitted a delaying amendment to the U.S. Securities and Exchange Commission (SEC) for its Registration Statement on Form S-3, originally filed on January 26, 2024. The amendment, dated January 29, 2024, is intended to delay the effective date of the registration statement. The company has included the delaying amendment language as required by Rule 473 of the Securities Act of 1933. This language indicates that the registration statement's effective date will be postponed until a further amendment is filed to specify its effectiveness in accordance with section 8(a) of the Securities Act, or until the SEC determines an effective date under the same section. Cardio Diagnostics Holdings has provided contact information for Rupert Russell for any questions or comments from the SEC staff.

Cardio Diagnostics Holdings, Inc. has submitted a delaying amendment to the U.S. Securities and Exchange Commission (SEC) for its Registration Statement on Form S-3, originally filed on January 26, 2024. The amendment, dated January 29, 2024, is intended to delay the effective date of the registration statement. The company has included the delaying amendment language as required by Rule 473 of the Securities Act of 1933. This language indicates that the registration statement's effective date will be postponed until a further amendment is filed to specify its effectiveness in accordance with section 8(a) of the Securities Act, or until the SEC determines an effective date under the same section. Cardio Diagnostics Holdings has provided contact information for Rupert Russell for any questions or comments from the SEC staff.